Abstract:Transformed lung organoids have extensive applications in lung cancer modeling and drug screening. Traditional two-dimensional (2D) cultures fail to propagate a large subpopulation of murine primary tumors in vitro. However, three-dimensional (3D) air-liquid interface (ALI) cultures, which are employed to grow normal lung organoids, can be used to efficiently culture cancerous lung tumor cells. Here, we detail a procedure for cultivating genetically modified lung organoids in 3D-ALI cultures. This protocol contains two parts. The first part describes how to transduce lung epithelial cells, which are either freshly sorted from lungs or from actively growing murine organoids, with virus in order to modify gene expression. The target lung cells are incubated with virus for 1-2 h for transduction. Then, the transduced cells are thoroughly washed and mixed with stromal support cells and Matrigel and are loaded into transwell inserts for culture and validated for genetic modifications through downstream assays. The second part describes how to isolate tumor cells growing orthotopically in genetically engineered mouse models to produce organoid cell lines that can be used for ex vivo drug discovery assays. For this protocol, tumors are isolated from lungs of mice, finely chopped and washed. Then, tumor chunks are mixed with Matrigel for 3D-ALI culture. Finally, organoids budding from tumor chunks are trypsinized and passaged to establish an organoid line. Together these two protocols provide a promising platform to study the genesis, progression, and treatment of lung cancer.

Lung Organoids for Hazard Assessment of Nanomaterials

Pluripotent Stem Cells: an in Vitro Model for Nanotoxicity Assessments

Human Lung Organoids—A Novel Experimental and Precision Medicine Approach

Lung Organoids—The Ultimate Tool to Dissect Pulmonary Diseases?

Lung Organoids and Their Use To Study Cell-Cell Interaction

Lung organoids: current uses and future promise

Lung Organoids: Systematic Review of Recent Advancements and its Future Perspectives

Use of three-dimensional organoids and lung-on-a-chip methods to study lung development, regeneration and disease

Generation of Complete Multi−Cell Type Lung Organoids From Human Embryonic and Patient‐Specific Induced Pluripotent Stem Cells for Infectious Disease Modeling and Therapeutics Validation

Organoids As a Powerful Model for Respiratory Diseases

Open questions in human lung organoid research

Novel Organoid Culture System for Improved Safety Assessment of Nanomaterials

Non-small Cell Lung Cancer Organoids: Advances and Challenges in Current Applications.

Using 3-Dimensional Cultures to Propagate Genetically Modified Lung Organoids

Recent advances in lung organoid development and applications in disease modeling

Alveolar Organoids in Lung Disease Modeling

A distal lung organoid model to study interstitial lung disease, viral infection and human lung development

Lung organoids, useful tools for investigating epithelial repair after lung injury

Advanced lung organoids for respiratory system and pulmonary disease modeling

Isolation, Culture, and Phenotypic Analysis of Murine Lung Organoids

Organoids in Lung Cancer Management